If there are any Canadian CML patients who take Bosutinib in this group,
please read this request from the CML Society and please please please
respond to the survey.
It is important that we put as much pressure as we can on our governments
to help move the approval process along.
Société de la LMC (leucémie myéloïde chronique)
*CmlSociety.org *
Bosutinib Experience in Canada
June 11, 2014
Canadian CML Patient’s who have been or are currently being treated with
Bosutinib. Please complete our survey.We are submitting data to PCODR
(Pan-Canadian Oncology Drug Review) that may help us win a favorable review
for Bosutinib reimbursement in Canada. The data from the survey must be
sent in before 5:00 PM on June 13th, so we need your responses by 12:00
noon on June 12th in order to tabulate and formalize our submission.
The PCODR review process helps provincial governments to decide if a drug
should be eligible for reimbursement. We all know how important it is to
have access to these life saving drugs.
It is very important that we help make sure that the patients voice is
being heard and this submission to PCODR is one of the best ways yet.
If you know someone who may be taking Bosutinib or had experience with
Bosutinib, please share this link and/or email with them.
https://www.surveymonkey.com/s/BOSUTINBPCODR
--
--
[CMLHope]
A support group of http://cmlhope.com
-------------------------------------------------
You received this message because you are subscribed to the Google Groups
"CMLHope" group.
To post to this group, send email to [email protected]
To unsubscribe from this group, send email to
[email protected]
For more options, visit this group at http://groups.google.com/group/CMLHope
---
You received this message because you are subscribed to the Google Groups
"CMLHope" group.
To unsubscribe from this group and stop receiving emails from it, send an email
to [email protected].
For more options, visit https://groups.google.com/d/optout.
